MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 2.780
0.00 (0.00%)
Aug 3, 2026, 2:53 PM CET
MaaT Pharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -31.06 | -28.9 | -19.72 | -13.71 | -9.02 |
Depreciation & Amortization | 1.74 | 1.69 | 0.87 | 0.43 | 0.33 |
Stock-Based Compensation | 1.67 | 1.53 | 0.87 | 0.65 | 0.79 |
Other Adjustments | 1.05 | 0.27 | -0.31 | 0.08 | 0.19 |
Change in Receivables | -0.05 | -0.95 | 0.35 | -0.32 | -0.39 |
Changes in Inventories | -0.02 | 0.13 | -0.14 | -0.01 | -0.03 |
Changes in Accounts Payable | 2.99 | 2.48 | 1.84 | 2.04 | 1.07 |
Changes in Accrued Expenses | 0.05 | 0.01 | 0.06 | 0.03 | 0.05 |
Changes in Other Operating Activities | 7.93 | 1.72 | -2.49 | -1.78 | -0.91 |
Operating Cash Flow | -15.72 | -22.04 | -18.67 | -12.61 | -7.93 |
Operating Cash Flow Growth | - | - | - | - | - |
Capital Expenditures | -0.61 | -0.75 | -1.09 | -0.66 | -0.24 |
Sale of Property, Plant & Equipment | 0 | - | - | - | - |
Proceeds from Sale of Investments | 0.2 | - | - | - | - |
Other Investing Activities | 0.14 | 0.34 | 0.65 | -0.15 | 0 |
Investing Cash Flow | -0.27 | -0.42 | -0.44 | -0.82 | -0.24 |
Long-Term Debt Issued | 3.24 | 5.12 | - | 7.48 | 0.46 |
Long-Term Debt Repaid | -2.89 | -3.58 | -4.19 | -1.93 | -0.95 |
Net Long-Term Debt Issued (Repaid) | 0.35 | 1.54 | -4.19 | 5.55 | -0.49 |
Issuance of Common Stock | 20.81 | 17.26 | 12.59 | 0.1 | 32.44 |
Repurchase of Common Stock | -0.05 | 0.02 | -0.08 | -0.14 | - |
Net Common Stock Issued (Repurchased) | 20.77 | 17.28 | 12.51 | -0.04 | 32.44 |
Other Financing Activities | -0.42 | -0.49 | -0.18 | -0.15 | -0.39 |
Financing Cash Flow | 20.7 | 18.33 | 8.14 | 5.36 | 31.56 |
Net Cash Flow | 4.71 | -4.13 | -10.97 | -8.06 | 23.39 |
Free Cash Flow | -16.33 | -22.79 | -19.76 | -13.27 | -8.17 |
Free Cash Flow Growth | - | - | - | - | - |
FCF Margin | -360.88% | -708.77% | -886.92% | -927.76% | -840.46% |
Free Cash Flow Per Share | -1.02 | -1.74 | -1.74 | -1.34 | -3.37 |
Levered Free Cash Flow | -18.64 | -22.09 | -24.07 | -8.13 | -8.45 |
Unlevered Free Cash Flow | -17.66 | -23.16 | -20.2 | -13.52 | -7.89 |